Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

147.75 +2.10 (+1.44%)
Official Closing Price Updated: 4:10 PM EST, Jan 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,628,686
Open 145.63
Bid (Size) 146.88 (2)
Ask (Size) 147.69 (3)
Prev. Close 145.65
Today's Range 144.41 - 147.85
52wk Range 133.05 - 175.91
Shares Outstanding N/A
Dividend Yield 3.52%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
Amgen launched its biosimilar knockoff on Tuesday at a steep discount. 
Via Investor's Business Daily
These 3 Healthcare Stocks With Over 3% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga

Performance

YTD
-9.01%
-9.01%
1 Month
-9.01%
-9.01%
3 Month
+0.92%
+0.92%
6 Month
+5.37%
+5.37%
1 Year
+7.93%
+7.93%

More News

Read More
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
Via Talk Markets
Down 14.5%, Is Pfizer Stock a Screaming Buy?
Via The Motley Fool
S&P Global, AbbVie, And This Big 3 Automaker On CNBC's 'Final Trades'
Via Benzinga
2 of the Best Dividend Stocks to Own in 2023
Via The Motley Fool
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Via Benzinga
2 Top Passive-Income Stocks to Own in 2023
Via The Motley Fool
AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry.
Via The Motley Fool
7 Dividend Stocks to Buy Now or You’ll Be Kicking Yourself Later
Via InvestorPlace
5 Cheapest Health Care Stocks You Should Think About
Via Benzinga
3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later
Via InvestorPlace
3 Reasons to Buy AbbVie and 2 Reasons Not to Buy
Via The Motley Fool
Want Safety and Growth in 2023? Try These Dividend Stocks.
Via The Motley Fool
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Via MarketBeat
Charles River Laboratories, AbbVie, Star Bulk Carriers And This Big Bank Are CNBC's 'Final Trades'
Via Benzinga
7 Stocks Every Smart Investor Should Own in 2023
Via InvestorPlace
3 Unstoppable Stocks to Keep Buying in 2023
Via The Motley Fool
AbbVie Stock: Dividend King ABBV Overview
Via MarketBeat
7 Biotech Stocks That Will Make You Rich in 10 Years
Via InvestorPlace
2 Cheap Growth Stocks That Can Set You Up for Life
Via The Motley Fool
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Via Talk Markets
Could This FDA Approval Boost AbbVie's Stock?
Via The Motley Fool
With Competition on the Rise, Is AbbVie's Dividend Safe?
Via The Motley Fool
AbbVie, Eli Lilly Leave UK's Voluntary Medicines Pricing Agreement Over Increasing Prices
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.